CCEI



Biomedical Entrepreneurship course to be offered fall 2020

The Daily Campus – Applications are open for a three-credit Biomedical Entrepreneurship course that will be offered during the Fall 2020 semester. The course, cross-listed as BME 6086-020, BADM 5894-011 and MGMT 5895, will be held on Tuesdays from 6 to 9 p.m. at the Connecticut Center for Entrepreneurship and Innovation in Hartford, according to the online course description.


UConn Entrepreneurship Program Celebrates Major Milestone

UConn Today – Accelerate UConn, an entrepreneurship program that helps students and faculty commercialize business ideas, reached a major milestone at the end of last year. Launched in 2015, Accelerate UConn announced that 100 teams of aspiring entrepreneurs had participated in the rigorous, seven-week training funded by the National Science Foundation’s I-Corps Program.





‘It’s ridiculously hard to make a startup succeed.’ Hartford’s new medtech accelerator is focused on improving these odds

Hartford Courant – With Hartford pushing to raise its profile as a hotbed of entrepreneurship and innovation, the first class of fledgling companies chosen for downtown’s new medtech accelerator focused squarely Tuesday on beating the odds stacked against startups.

Opo



Top Schools for Entrepreneurship Studies 2020 Press Release

The Princeton Review – Based on data the education services company collected from more than 300 schools with offerings in entrepreneurship studies, The Princeton Review’s ranking lists for 2020 name 50 undergraduate and 25 graduate schools as outstanding choices for students aspiring to become entrepreneurs.

Opo


Nami Therapeutics Startup Pursues Promising Drug Therapy

UConn Today – Nami Therapeutics Corporation, which gets its name from the Mandarin word for “nano,” is committed to using nanotechnologies to make big advances in cancer therapy. An early-stage startup led by researchers at the University of Connecticut and the University of North Carolina at Chapel Hill, Nami Therapeutics is developing specifically designed nanoparticles for targeted drug delivery.

Opo